Under the pressure of oncogenic stimuli such as MYCN aberrant expression, dysregulation of the signaling pathway in neural crest cell may generate highly malignant NB cancer stem cells (CSC) subsets (Olsen et al., 2017). The gene discussed is MYCN; the disease is neuroblastoma.